drugset / Trial / NCT01948024

Bio-equivalence Study Between SAPHRIS and Asenapine

NCT01948024

RandomizedCrossoverOpen-labelOther

Summary

This is a Multiple-dose, steady state, three-way reference-replicated crossover study. The purpose of this Study is to determine the bio-equivalence between SAPHRIS and Asenapine 10mg sublingual tablets.

Timeline

Start
2013-07
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Asenapine Other / unclassified 10 mg Other